Neoadjuvant chemoradiotherapy with or without panitumumab in patients with wild-type KRAS, locally advanced rectal cancer (LARC): a randomized, multicenter, phase II trial SAKK 41/07Daniel Helbling, Dieter Koeberle, Roger Burkhard et al.|Annals of Oncology|2012Cited by 86
Neoadjuvant chemoradiation (CRT) with or without panitumumab (Pan) in patients with K-ras-unmutated, locally advanced rectal cancer (LARC): A randomized multicenter phase II trial (SAKK 41/07).Daniel Helbling, Dieter Koeberle, G. Bodoky et al.|Journal of Clinical Oncology|2011Cited by 4
Neoadjuvant chemoradiation (CRT) with or without panitumumab (Pan) in patients with K-ras unmutated, locally advanced rectal cancer (LARC): Final results of a randomized multicenter phase II trial (SAKK 41/07).Daniel Helbling, Dieter Koeberle, G. Bodoky et al.|Journal of Clinical Oncology|2015Cited by 0